bpc 157 clinical trials human evidence safety bpc-157 review regulatory status BPC‑157 — 10 mg bpc-157 human clinical trials evidence
Description
Reconstituted Solution: Once mixed with liquid, store inside a secure refrigerator at 28C
Daily injection compliance matters: GHK-Cu requires daily subcutaneous injection, which is not the right fit for patients who only want to inject their GLP-1 once a week
The trials tested oral, intravenous, and subcutaneous routes of administration at doses ranging from micrograms to 1 mg per day
BAC contains 0.9% benzyl alcohol, which helps prevent bacterial growth, ensuring stability during experiments
